Percutaneous Transhepatic Embolization Of Gastroesophageal Varices Combined With Partial Splenic Embolization For The Treatment Of Variceal Bleeding And Hypersplenism

This study aims to evaluate the therapeutic results of percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization in patients with liver cirrhosis, and to explore the role of this minimally invasive treatment as an alternative to surgery. 25 patients with liver cirrhosis were received percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization. Another 25 patients with liver cirrhosis underwent Hassab's operation. They were followed up, and received endoscopy, B ultrasound, liver function and hematologic examination at 24 months after the therapy. In minimal invasive group, before treatment and after 24 month following up after treatment, improved varices, improved portal hypertension and improved hypersplenism were showed comparing with the surgery group, and that they were measured by endoscopic visualization, ultrasound and blood counts. the white blood cell and platelet count were 2.33 +/- 0.65 (10(9)/L) and 3.63 +/- 1.05 (10(10)/L), 7.98 +/- 3.0 (10(9)/L) and 16.3 +/- 9.10 (10(10)/L) (P< 0.05); the diameter of the portal vein were 1.47 +/- 0.25 cm, 1.31 +/- 0.23 cm (P< 0.05). Esophageal varices passed from grade III to lower grade II in 11 patients, and from grade II to lower grade I in 6 patients at 24 month following up. In surgical group, the white blood cell and platelet count were 2.2 +/- 0.60 (10(9)/L), 4.1 +/- 1.25 (10(10)/L) before treatment; 9.3 +/- 2.56 (10(9)/L), 32.1 +/- 12.47 (10(10)/L) after the treatment at 24 month following up (P< 0.05). The diameter of the portal vein were 1.43 +/- 0.22 cm before the treatment and 1.28 +/- 0.18 cm after the treatment (P< 0.05). Esophageal varices passed from grade III to lower grade II in 13 patients, and from grade II to lower grade I in 7 patients. The combination of PGEV and PSE can be considered as an option for the treatment of variceal bleeding with hypersplenism.